When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...

LHRH-agonists in Early Breast Cancer Overview group (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive ...

A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy.

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Participants were randomly allocated (in a 2:1 ratio) to receive estrogen patches or an LHRH analog. At the release of these preliminary results, 13 patients had received Fem7 ® and had ≥12 ...